Dermatology

Lebrikizumab maintained deep skin responses and sustained itch improvements for up to three years in early responders with moderate-to-severe atopic dermatitis, with infrequent flares among stable responders.

Treatment-emergent skin toxic effects during first-line enfortumab vedotin plus pembrolizumab were associated with longer overall survival.

An Australian cohort study evaluating six melanoma risk prediction models found moderate discrimination and variable calibration, with most models underestimating observed melanoma cases.

Auricular acupressure for rosacea improved treatment success and vascular measures in a randomised, sham-controlled trial.

Lichen planus cancer risk was elevated for oral and genital cancers in a Danish cohort, although absolute risks remained low.

An international study found that CLIPI scores distinguished progression risk and treatment response in advanced mycosis fungoides and Sézary syndrome, improving prognostic discrimination beyond baseline clinical stage.

A study of 451 adults with systemic lupus erythematosus found widespread dietary supplement use and potential supplement–medication interactions in nearly one-third of participants.

K17hi hair follicle cells were linked to psoriatic inflammation through the TCF12-S100A1-ANXA2 pathway, identifying a potential therapeutic target.